These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11509079)

  • 1. T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow-up study.
    Sailer M; Losseff NA; Wang L; Gawne-Cain ML; Thompson AJ; Miller DH
    Eur J Neurol; 2001 Jan; 8(1):37-42. PubMed ID: 11509079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy.
    Taylor I; Butzkueven H; Litewka L; MacGregor LR; Szoeke C; Cook M; Mitchell P; Kilpatrick TJ; Tubridy N
    J Clin Neurosci; 2004 Feb; 11(2):153-8. PubMed ID: 14732374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy.
    Stevenson VL; Smith SM; Matthews PM; Miller DH; Thompson AJ
    J Neurol; 2002 Feb; 249(2):171-7. PubMed ID: 11985382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis.
    Giugni E; Pozzilli C; Bastianello S; Gasperini C; Paolillo A; Koudriavtseva T; Frontoni M; Farina D; Bozzao L
    Mult Scler; 1997 Aug; 3(4):221-5. PubMed ID: 9372503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis.
    Filippi M; Mastronardo G; Rocca MA; Pereira C; Comi G
    J Neurol Sci; 1998 Jun; 158(2):148-53. PubMed ID: 9702685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a.
    Gasperini C; Paolillo A; Giugni E; Galgani S; Bagnato F; Mainero C; Onesti E; Bastianello S; Pozzilli C
    Mult Scler; 2002 Apr; 8(2):119-23. PubMed ID: 11990868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.
    Bakshi R; Neema M; Healy BC; Liptak Z; Betensky RA; Buckle GJ; Gauthier SA; Stankiewicz J; Meier D; Egorova S; Arora A; Guss ZD; Glanz B; Khoury SJ; Guttmann CR; Weiner HL
    Arch Neurol; 2008 Nov; 65(11):1449-53. PubMed ID: 19001162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
    Elliott C; Belachew S; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Fecker J; Model F; Wei W; Arnold DL
    Brain; 2019 Sep; 142(9):2787-2799. PubMed ID: 31497864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
    Nijeholt GJ; van Walderveen MA; Castelijns JA; van Waesberghe JH; Polman C; Scheltens P; Rosier PF; Jongen PJ; Barkhof F
    Brain; 1998 Apr; 121 ( Pt 4)():687-97. PubMed ID: 9577394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative MRI analysis of cerebral lesions and atrophy in post-partum patients with multiple sclerosis.
    Khalid F; Healy BC; Dupuy SL; Chu R; Chitnis T; Bakshi R; Houtchens M
    J Neurol Sci; 2018 Sep; 392():94-99. PubMed ID: 30031994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability.
    Valsasina P; Aboulwafa M; Preziosa P; Messina R; Falini A; Comi G; Filippi M; Rocca MA
    Radiology; 2018 Jul; 288(1):234-244. PubMed ID: 29664341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis.
    Janardhan V; Bakshi R
    Arch Neurol; 2000 Oct; 57(10):1485-91. PubMed ID: 11030802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-beta-1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted images.
    Gasperini C; Pozzilli C; Bastianello S; Giugni E; Horsfield MA; Koudriavtseva T; Galgani S; Paolillo A; Haggiag S; Millefiorini E; Fieschi C
    J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):579-84. PubMed ID: 10519861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
    van Walderveen MA; Lycklama A Nijeholt GJ; Adèr HJ; Jongen PJ; Polman CH; Castelijns JA; Barkhof F
    Arch Neurol; 2001 Jan; 58(1):76-81. PubMed ID: 11176939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings.
    Kimiskidis VK; Papaliagkas V; Sotirakoglou K; Kouvatsou ZK; Kapina VK; Papadaki E; Tsimourtou V; Masoura E; Kazis DA; Papayiannopoulos S; Geroukis T; Bostanjopoulou S
    Mult Scler Relat Disord; 2016 Nov; 10():192-197. PubMed ID: 27919489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta.
    Paolillo A; Pozzilli C; Giugni E; Tomassini V; Gasperini C; Fiorelli M; Mainero C; Horsfield M; Galgani S; Bastianello S; Buttinelli C
    Eur J Neurol; 2002 Nov; 9(6):645-55. PubMed ID: 12453081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability.
    Kerbrat A; Gros C; Badji A; Bannier E; Galassi F; Combès B; Chouteau R; Labauge P; Ayrignac X; Carra-Dalliere C; Maranzano J; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Tachibana Y; Hori M; Kamiya K; Chougar L; Lefeuvre J; Reich DS; Nair G; Valsasina P; Rocca MA; Filippi M; Chu R; Bakshi R; Callot V; Pelletier J; Audoin B; Maarouf A; Collongues N; De Seze J; Edan G; Cohen-Adad J
    Brain; 2020 Jul; 143(7):2089-2105. PubMed ID: 32572488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: relation to inflammatory activity.
    van Walderveen MA; Truyen L; van Oosten BW; Castelijns JA; Lycklama à Nijeholt GJ; van Waesberghe JH; Polman C; Barkhof F
    Arch Neurol; 1999 Mar; 56(3):345-51. PubMed ID: 10190826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.